Polycystic Ovary Syndrome: A Comprehensive Review

    July 2009 in “ Journal Of Endocrinology, Metabolism And Diabetes Of South Africa ”
    Sureka Maharaj, Aslam Amod
    Image of study
    TLDR The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.
    The 2009 document provides a detailed review of Polycystic Ovary Syndrome (PCOS), a common endocrinopathy affecting 5-10% of women of reproductive age, characterized by hyperandrogenism, anovulation, and polycystic ovarian morphology (PCOM). It discusses the evolution of diagnostic criteria, the heterogeneity of the condition, and the associated risks of metabolic syndrome and infertility. The review also covers clinical and biochemical assessment of hyperandrogenism, the use of trans-vaginal ultrasound for PCOM, and the differentiation of PCOS from other conditions. It highlights that 50% of women with PCOS have insulin resistance (IR), and there is a 7-fold increased risk of type 2 diabetes, as well as increased cardiovascular risks and obstetric complications. Treatment focuses on symptom management and improving long-term outcomes, with lifestyle modification as a key strategy. For hirsutism, spironolactone and topical eflornithine are recommended as first-line treatments, while metformin is recognized for preventing diabetes but not as effective for weight loss or menstrual regularity. The document emphasizes that management should address both symptoms and metabolic consequences.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    6 / 1000+ results